Hong Kong stock exchange filings revealed that on July 15, a major shareholder of WuXi AppTec (02359.HK) transferred holdings valued at HK$1.051 billion from Hongkong and Shanghai Banking Corporation Limited to Citibank. This transaction represented 3.08% of the company's issued shares. Concurrently, Goldman Sachs revised its financial projections for the pharmaceutical giant, lifting the 2024 revenue forecast by 2.3% to RMB44 billion. This adjustment primarily reflects stronger-than-expected growth in WuXi AppTec's TIDES business segment. The investment bank also upgraded its earnings per share estimates for 2025 through 2027, boosting projections by 3.8%, 4%, and 3.5% respectively. Goldman consequently raised its H-share target price from HK$74.9 to HK$85.5.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。